Showing results (961-970 of 1,155) with videos related to

Sort By:
Pageof 116
Plos One|August 15, 2018
Age- and sex-dependent changes in sympathetic activity of the left ventricular apex assessed by 18F-DOPA PET imagingIrene A Burger, Christine Lohmann, Michael Messerli, et al.
JAMA Oncology|July 17, 2020
Adjuvant Systemic Chemotherapy vs Active Surveillance Following Up-front Resection of Isolated Synchronous Colorectal Peritoneal MetastasesKoen P Rovers, Checca Bakkers, Felice N van Erning, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 3, 2021
Metabolic positron emission tomography/CT response after induction chemotherapy and chemo(re)irradiation is associated with higher negative resection margin rate in patients with locally recurrent rectal cancerDesley M G I van Zoggel, Eva L K Voogt, Ineke G van Lijnschoten, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 18, 2020
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapyMarco M E Vogel, Stephanie G C Kroeze, Christoph Henkenberens, et al.
Blood|July 26, 2019
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLLConstantine S Tam, Judith Trotman, Stephen Opat, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 29, 2024
Intraperitoneal pharmacokinetics of systemic oxaliplatin, 5-fluorouracil and bevacizumab in patients with colorectal peritoneal metastasesPascale C S Rietveld, Niels A D Guchelaar, Ruben A G van Eerden, et al.
European Urology Focus|September 10, 2019
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen DeprivationStephanie G C Kroeze, Christoph Henkenberens, Nina Sophie Schmidt-Hegemann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 1, 2020
Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy-a multicenter retrospective studyN-S Schmidt-Hegemann, S G C Kroeze, C Henkenberens, et al.
Lancet (London, England)|March 22, 2015
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosisRodney Dawson, Andreas H Diacon, Daniel Everitt, et al.
Journal of Contemporary Brachytherapy|October 6, 2022
Narrowing the difference in dose delivery for IOERT and IOBT for locally advanced and locally recurrent rectal cancerAn-Sofie E Verrijssen, Wim J F Dries, Jeltsje S Cnossen, et al.
Pageof 116